Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
Clinical trial NCT01924195 · COMPLETED
Trial details
- NCT number
- NCT01924195
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-03-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.